Novartis | NVS - Biaya Penjualan

Harga Saham
150.45
Perubahan Harian
0.06 0.04%
Bulanan
1.68%
Tahunan
33.37%
Q2 Perkiraan
145.13




Biaya Penjualan Perubahan Tanggal
AbbVie USD 4.22B 329M 2026-03
Amgen USD 1.6B 187M 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Bausch Health Companies USD 979M 55M 2026-03
Biogen USD 797.5M 302M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Canopy Growth CAD 53.08M 8.3M 2025-12
Corcept Therapeutics USD 2.88M 338K 2026-03
Drreddys Laboratories INR 40.46B 3.64B 2025-12
Eli Lilly USD 3.58B 205M 2026-03
Gilead Sciences USD 1.44B 174M 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
Glaxosmithkline GBP 3.47B 461.37M 2025-12
J&J USD 8.07B 103M 2026-03
Merck USD 2.94B 380M 2026-03
Novartis USD 3.46B 83M 2026-03
Novartis USD 3.54B 7M 2025-12
Pacira USD 50.74M 3.89M 2026-03
Perrigo USD 643.7M 103.7M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 140.76M 9.53M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
Sanofi EUR 3.76B 344M 2025-12
Supernus Pharmaceuticals USD 49.04M 1.5M 2026-03
Zoetis USD 672M 71M 2026-03